The genetics of atherothrombotic disorders: a clinician's view

@article{Grant2003TheGO,
  title={The genetics of atherothrombotic disorders: a clinician's view},
  author={P. Grant},
  journal={Journal of Thrombosis and Haemostasis},
  year={2003},
  volume={1}
}
  • P. Grant
  • Published 2003
  • Medicine
  • Journal of Thrombosis and Haemostasis
Summary.  The development of coronary artery disease is dependent on the interaction of multiple biochemical pathways that lead to the development of plaque in the arterial wall and ultimately plaque instability, plaque rupture and thrombosis. The latter stages lead to vascular obstruction, tissue death and the final phenotype of myocardial infarction. Hemostasis gene association studies of atherothrombotic disorders have been unrewarding, with largely underpowered studies reporting… Expand
Is hypercoagulability an issue in arterial thrombosis? Yes
  • P. Grant
  • Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2004
Cardiovascular disease and heritability of the prothrombotic state.
Coagulation and atherothrombotic disease.
Is hypercoagulability an issue in arterial thrombosis? No
  • P. Reitsma
  • Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2004
The metabolic syndrome: a vascular perspective.
Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease
...
1
2
3
4
...

References

SHOWING 1-10 OF 156 REFERENCES
Plasminogen-activator inhibitor type 1 and coronary artery disease.
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia
  • G. Reaven
  • Medicine
  • Diabetes, obesity & metabolism
  • 2002
Genetic polymorphisms and coronary artery disease in the south of France.
...
1
2
3
4
5
...